About Us

Mission of the Board and Committees.

The Preventing Overdiagnosis Board is responsible for the oversight of the international Preventing Overdiagnosis scientific conferences and associated activities, including maintenance of the website: www.PreventingOverdiagnosis.net.

Each of the partners and representation from other key organisations in Preventing Overdiagnosis will be represented on the board, including The BMJ, Wiser Healthcare, the University of Oxford’s Centre for Evidence Based Medicine, and The Dartmouth Institute for Health Policy and Clinical Practice. Each board member will also have a ‘second’ who can attend meetings. While primarily an international scientific meeting, the conference encourages clinicians, policy-makers and citizen organisations to participate, as well as researchers.

The primary aim of the Board is to develop strategies to sustain the international scientific conferences. Other aims include: to encourage national or regional conferences; encourage research generation and dissemination on the problem of overdiagnosis and potential solutions; encourage the development of educational curricula; encourage development and evaluation of strategies to communicate about overdiagnosis; encourage the development of a community or network of clinicians, researchers, policy-makers and citizen advocates with an interest in the area; develop explicit guidance for constitution of the board and committees.

Functions of the Board include oversight of: the development of the scientific program for the international conference; the conference website; the conference budget; appointments to the committees, including the scientific committee and the local organising sub-committee mentioned below; approval of any contractual engagements related to the management of the conference; approval of the use of the Preventing Overdiagnosis name/logo by any national or regional meetings.

 

Preventing Overdiagnosis is a not for profit group.

Policies of the Board include: a strict policy of no industry funding or sponsorship, either direct or indirect, in any form, for all Preventing Overdiagnosis conferences and associated activities, and thus no exhibitor’s hall; an aspiration to keep the conference registration fee as low as possible, in order to encourage wide participation including from trainees/students; an aim to include citizen participants in the conference. Industry is defined as including for-profit companies/organisations which sell products including, but not limited to: healthcare services, medications, devices or insurance policies – or related organisations. More detailed policy-guidance will be developed as needed. Any surplus generated by the conference, after all costs are covered, will be used to further the explicit aims and functions expressed here.

The scientific committee has responsibility for developing the international conference scientific programme, abstract submission topics, and keynote speakers. The PODC Board has responsibility for deciding on future locations/hosts, selecting the scientific committee, and helping develop strategies to sustain the conference and related activities. The scientific committee has a Research Day sub-committee, which will have oversight of the Research Day associated with the main international conference. The Local Organising sub-committee will have responsibility for managing all aspects of the conference planning, including venues, budgets, onsite materials, speaker liaison and website content management. This will be constituted annually, and will include at least one representative from the host institution.

 

Board
John Brodersen
 University of Copenhagen
Paul Glasziou Centre for Research in Evidence-Based Practice Bond University 
Fiona Godlee Editor in Chief British Medical Journal 
Carl Heneghan Centre for Evidence-Based Medicine University of Oxford 
Lisa Schwartz Dartmouth Institute for Health Policy and Clinical Practice 
Steve Woloshin Dartmouth Institute for Health Policy and Clinical Practice
Iona Heath Medical Doctor

Scientific Committee 2019
Co-Chair – Alexandra Barratt
 University of Sydney
Co-Chair – Ray Moynihan Bond University
Rachelle Buchbinder Monash University and Cabrini Institute
Jenny Doust
 Bond University
Karsten Juhl Jørgensen

Barnett Kramer National Cancer Institute, US
Helen MacDonald British Medical Journal
Tara Montgomery Founder & Principal Civic Health Partners
John Brodersen
 University of Copenhagen
Lisa Schwartz Dartmouth Institute for Health Policy and Clinical Practice
Hazel Thornton Honorary Visiting Fellow, University of Leicester
Steve Woloshin Dartmouth Institute for Health Policy and Clinical Practice
Sachiko Ohde St Lukes International University

Junior Researcher Committee 2019
Tessa Copp University of Sydney
Jolyn Hersch
 University of Sydney
Brooke Nickle University of Sydney
Matthew Yu Wang Department of Global Health School of Public Health Peking University
Minna Johansson University of Gothenburg
Fredrik Martiny University of Copenhagen
Jack O’Sullivan University of Oxford
Julian Treadwell University of Oxford
Gemma JacklynUniversity of Sydney
Georgia Richards University of Oxford

Local Organising Committee 2019
Alexandra Barratt University of Sydney
Stacy Carter University of Wollongong
Tom Dakin University of Sydney
Rachael Dodd University of Sydney
Jenny Doust Bond University
Rachel Farber University of Sydney
Chris Semsarian Centenary Institute
Christopher Maher
University of Sydney
Kirsten McCaffery University of Sydney
Denise O’Connor Monash University
Kirsten Pickles University of Sydney
Ray Moynihan Bond university
Stephanie Mathieson University of Sydney

Preventing Overdiagnosis Research and Involvement – info@preventingoverdiagnosis.net
Conference information – ruth.davis@phc.ox.ac.uk